NYSE:CLBCore Laboratories Stock Price, Forecast & News

Core Laboratories' stock was trading at $10.93 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, CLB stock has increased by 93.4% and is now trading at $21.14. View which stocks have been most impacted by Coronavirus.

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Core Laboratories in the last year. There are currently 1 sell rating, 11 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Core Laboratories.

Core Laboratories is scheduled to release its next quarterly earnings announcement on Wednesday, July 22nd 2020. View our earnings forecast for Core Laboratories.

Core Laboratories (NYSE:CLB) posted its quarterly earnings results on Wednesday, April, 22nd. The oil and gas company reported $0.31 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.33 by $0.02. The oil and gas company earned $152.40 million during the quarter, compared to analyst estimates of $151.37 million. Core Laboratories had a negative net margin of 7.21% and a positive return on equity of 46.28%. The firm's revenue was down 9.9% compared to the same quarter last year. During the same period in the previous year, the business earned $0.44 EPS. View Core Laboratories' earnings history.

Core Laboratories announced a quarterly dividend on Tuesday, April 28th. Stockholders of record on Friday, May 8th will be given a dividend of $0.01 per share on Tuesday, May 19th. This represents a $0.04 dividend on an annualized basis and a dividend yield of 0.19%. The ex-dividend date of this dividend is Thursday, May 7th. View Core Laboratories' dividend history.

15 equities research analysts have issued 1 year price targets for Core Laboratories' shares. Their forecasts range from $7.50 to $77.00. On average, they expect Core Laboratories' stock price to reach $30.93 in the next year. This suggests a possible upside of 46.3% from the stock's current price. View analysts' price targets for Core Laboratories.

Media headlines about CLB stock have been trending very negative on Thursday, according to InfoTrie Sentiment. InfoTrie ranks the sentiment of press coverage by analyzing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Core Laboratories earned a news sentiment score of -3.0 on InfoTrie's scale. They also gave news coverage about the oil and gas company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View the latest news aboutCore Laboratories.

Core Laboratories saw a increase in short interest in May. As of May 15th, there was short interest totaling 6,500,000 shares, an increase of 5.3% from the April 30th total of 6,170,000 shares. Based on an average trading volume of 1,890,000 shares, the short-interest ratio is presently 3.4 days. Approximately 14.8% of the company's shares are short sold. View Core Laboratories' Current Options Chain.

Some companies that are related to Core Laboratories include Subsea 7 (SUBCY), SemGroup (SEMG), RPC (RES), NexTier Oilfield Solutions (NEX), Oceaneering International (OII), Liberty Oilfield Services (LBRT), Select Energy Services (WTTR), Helix Energy Solutions Group (HLX), Propetro (PUMP), Franks International (FI), National Energy Services Reunited (NESR), Keane Group (FRAC), North American Construction Group (NOA), Hurricane Energy (HRCXF) and Key Energy Services (KEGX). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Core Laboratories investors own include CA (CA), BlackRock (BLK), Chipotle Mexican Grill (CMG), Endologix (ELGX), Starbucks (SBUX), Micron Technology (MU), Gilead Sciences (GILD), Netflix (NFLX), AT&T (T) and Baidu (BIDU).

Core Laboratories trades on the New York Stock Exchange (NYSE) under the ticker symbol "CLB."

Core Laboratories' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Van ECK Associates Corp (12.38%), Massachusetts Financial Services Co. MA (7.53%), BlackRock Inc. (6.65%), Clearbridge Investments LLC (4.11%), Bank of New York Mellon Corp (3.06%) and Deutsche Bank AG (2.21%). Company insiders that own Core Laboratories stock include Gregory Barry Barnett, Jan Willem Sodderland, Kevin Daniels, Lawrence Bruno and Mark F Elvig. View institutional ownership trends for Core Laboratories.

CLB stock was sold by a variety of institutional investors in the last quarter, including Massachusetts Financial Services Co. MA, JPMorgan Chase & Co., Nuveen Asset Management LLC, Wells Fargo & Company MN, Principal Financial Group Inc., BlackRock Inc., Baird Financial Group Inc., and Mcdonald Capital Investors Inc. CA. View insider buying and selling activity for Core Laboratories.

CLB stock was acquired by a variety of institutional investors in the last quarter, including Van ECK Associates Corp, Deutsche Bank AG, Luminus Management LLC, Bank of New York Mellon Corp, C Partners Holding GmbH, Morgan Stanley, Morgan Stanley, and Two Sigma Advisers LP. Company insiders that have bought Core Laboratories stock in the last two years include Gregory Barry Barnett, Jan Willem Sodderland, and Lawrence Bruno. View insider buying and selling activity for Core Laboratories.

Shares of CLB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CLB stock can currently be purchased for approximately $21.14.

Core Laboratories has a market capitalization of $939.82 million and generates $668.21 million in revenue each year. The oil and gas company earns $101.98 million in net income (profit) each year or $1.79 on an earnings per share basis. Core Laboratories employs 4,300 workers across the globe.

The official website for Core Laboratories is www.corelab.com.

Core Laboratories' mailing address is STRAWINSKYLAAN 913 TOWER A LEVEL 9, AMSTERDAM P7, 1077 XX. The oil and gas company can be reached via phone at 31-20-420-3191 or via email at [email protected]